Anu Osinusi

Anu Osinusi has extensive experience in clinical development, particularly in the fields of hepatitis, respiratory, and emerging viruses. At Gilead Sciences, Anu served as Vice President, Franchise Head for Hepatitis, COVID, and Respiratory and Emerging Viruses, having previously held roles as Exec Director, Clinical Development, and Director, Clinical Development within the organization. Anu's career also includes significant contributions as Clinical Director at the National Institutes of Health / DC Partnership for AIDS Progress and teaching as an Adjunct Assistant Professor of Medicine at the University of Maryland School of Medicine. Anu's clinical training includes a residency in Internal Medicine at Rush University Medical Center and early research experience as a Clinical Research Associate at the Institute of Human Virology and a Research Associate at Harvard T.H. Chan School of Public Health. Anu holds a Master of Public Health in Quantitative Methods from Harvard School of Public Health and a Doctor of Medicine from the University of Ibadan.